Initially, our findings suggest that CLPTM1L may influence cervical cancer cell proliferation through downstream candidate genes BOC and LRP2, while also playing a crucial role in regulating cisplatin-induced apoptosis via DAP1. This evidence concerns the gene LRP2 and cervical carcinoma.